Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen
Friday, October 30, 2020Protagonist Therapeutics Inc announced that two additional oral peptide IL receptor antagonist candidates from its collaboration agreement with Janssen Biotech Inc have been selected for advancement into clinical development
AbCellera and Kodiak Sciences Enter Second Antibody Discovery Collaboration for Ophthalmology Targets
Friday, October 30, 2020AbCellera and Kodiak Sciences Incannounced a new partnership to generate therapeutic antibody candidates in ophthalmology Following a previously successful collaboration AbCellera will use its full stack AIpowered antibody discovery technology to dis...
Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications
Thursday, October 29, 2020Releviate Therapeutics a biopharmaceutical company addressing the needs of patients suffering from chronic pain signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers at the University of California Riv...
Insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments
Thursday, October 29, 2020Insitro a machinelearning driven drug discovery and development company today announced that it has entered into a fiveyear discovery collaboration with Bristol Myers Squibb focused on the discovery and development of novel therapies for the treatmen...
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
Wednesday, October 28, 2020Histogen Inc a clinicalstage therapeutics company focused on developing potential firstinclass therapeutics that ignite the bodys natural process to repair and maintain healthy biological function today announced entering into a Collaborative Develop...
SFJ Pharmaceuticals® partner, Apellis, enters Strategic Collaboration with Sobi to Develop and Commercialize Pegcetacoplan in Hematologic Indications outside the U.S.
Wednesday, October 28, 2020SFJ Pharmaceuticals SFJ is pleased to note that its partner Apellis Pharmaceuticals Inc Apellis Waltham MA and Swedish Orphan Biovitrum AB announced a strategic collaboration to accelerate the advancement of systemic pegcetacoplan a targeted C therap...
Knight Signs New Exclusive Agreement for AmBisome® with Gilead in Brazil
Tuesday, October 27, 2020Knight Therapeutics Inc a leading Pan Americanspecialty pharmaceutical company Knight announced the signing of a new exclusive distribution agreement with Gilead Sciences Inc Gilead for the marketing of AmBisome liposomal amphotericin B in Brazil T...
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)
Tuesday, October 27, 2020CStone Pharmaceuticals announced an agreement to outlicense exGreater China rights for two key latestage immunooncology assets sugemalimab antiPDL and CS antiPD to EQRx a biopharmaceutical company with an innovative business model that will allow the...
Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy
Monday, October 26, 2020Bayer AG announced the acquisition of Asklepios BioPharmaceutical Inc AskBio a USheadquartered biopharmaceutical company specialized in the research development and manufacturing of gene therapies across different therapeutic areas
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
Saturday, October 24, 2020Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare diseases and Solid Biosciences Inc a life sciences company focused on advancing meaningful th...
